Works by Oñate, Guadalupe


Results: 10
    1
    2

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    3

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    4
    5

    Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
    By:
    • Bataller, Alex;
    • Oñate, Guadalupe;
    • Diaz‐Beyá, Marina;
    • Guijarro, Francesca;
    • Garrido, Ana;
    • Vives, Susana;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Salamero, Olga;
    • Sampol, Antònia;
    • Coll, Rosa;
    • Vall‐Llovera, Ferran;
    • Oliver‐Caldés, Aina;
    • López‐Guerra, Mònica;
    • Pratcorona, Marta;
    • Zamora, Lurdes;
    • Villamon, Eva;
    • Roué, Gaël;
    • Blanco, Adoración;
    • Nomdedeu, Josep F.
    Publication type:
    Article
    6
    7

    Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
    By:
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Arnan, Montserrat;
    • Pomares, Helena;
    • Alonso, Ester;
    • Tormo, Mar;
    • Diaz-Beya, Marina;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Sampol, Antonia;
    • Coll, Rosa;
    • Salamero, Olga;
    • Cervera, Marta;
    • Garcia, Antoni;
    • Vall-Llovera, Ferran;
    • Garcia-Avila, Sara;
    • Bargay, Joan;
    • Ortin, Xavier;
    • Iranzo, Eva;
    • Guijarro, Francisca
    Publication type:
    Article
    8

    Measurable Residual Disease in UBTF‐TD Adult Acute Myeloid Leukemia.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 6, p. 1052, doi. 10.1111/ejh.14402
    By:
    • Castellet, Helena;
    • Ramil, Guillermo;
    • Carricondo, Maite;
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Artigas, Alícia;
    • Pratcorona, Marta;
    • Salamero, Olga;
    • Cortés‐Bullich, Albert;
    • Vives, Susana;
    • Tormo, Mar;
    • Mascaró, Martí;
    • Gallardo, David;
    • Tutusaus, Josep Maria Marti;
    • Garcia, Antonio;
    • Sierra, Jorge;
    • Esteve, Jordi;
    • Nomdedéu, Josep
    Publication type:
    Article
    9

    Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation

    Published in:
    European Journal of Haematology, 2024, v. 113, n. 6, p. 776, doi. 10.1111/ejh.14294
    By:
    • Redondo, Sara;
    • García‐Cadenas, Irene;
    • Esquirol, Albert;
    • Portos, J. M.;
    • Iranzo, Eva;
    • Arguello‐Tomas, Miguel;
    • Saavedra, Silvana;
    • Oñate, Guadalupe;
    • Caballero, Ana‐Carolina;
    • Garrido, Ana;
    • López, Jordi;
    • Muntañola, Ana;
    • Paviglianiti, Annalisa;
    • Miqueleiz, Sara;
    • Sierra, Jorge;
    • Briones, Javier;
    • Martino, Rodrigo
    Publication type:
    Article
    10

    Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 1, p. 146, doi. 10.1111/ejh.13978
    By:
    • Redondo, Sara;
    • García‐Cadenas, Irene;
    • Vila, Antonio;
    • Esquirol, Albert;
    • Portos, J. M.;
    • Novelli, Silvana;
    • Saavedra, Silvana;
    • Moreno, Carol;
    • Garrido, Ana;
    • Arguello‐Tomas, Miguel;
    • Oñate, Guadalupe;
    • López‐Pardo, Jordi;
    • Caballero, Ana‐Carolina;
    • Miqueleiz, Sara;
    • Briones, Javier;
    • Sierra, Jorge;
    • Sancho, Gemma;
    • Martino, Rodrigo
    Publication type:
    Article